title: Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
authors.forename: S
authors.initials: S
authors.lastname: Faruqi
authors.forename: J
authors.initials: J
authors.lastname: McCreanor
authors.forename: T
authors.initials: T
authors.lastname: Moon
authors.forename: R
authors.initials: R
authors.lastname: Meigh
authors.forename: A H
authors.initials: AH
authors.lastname: Morice
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications* / Q000503:physiopathology; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012129:Respiratory Function Tests; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin